Use of nebulized heparin in the treatment of smoke inhalation injury

Journal of Burn Care and Research

Volumn 30, Issue 1, 2009, Pages 159-162

  Enkhbaatar, Perenlei ^a,b   Herndon, David N ^a,b   Traber, Daniel L ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; DIMETHYL SULFOXIDE; HEPARIN; LISOFYLLINE;

AIRWAY OBSTRUCTION; ANTIINFLAMMATORY ACTIVITY; ARTIFICIAL VENTILATION; CONFERENCE PAPER; LUNG BURN; LUNG DISEASE; LUNG EDEMA; NONHUMAN;

ADMINISTRATION, INHALATION; ANIMALS; ANTICOAGULANTS; HEPARIN; HUMANS; NEBULIZERS AND VAPORIZERS; SMOKE INHALATION INJURY;

EID: 59449106685     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3181923bd3     Document Type: Conference Paper

References (23)

1. Sakurai H, Soejima K, Nozaki M, Traber L, Traber D. Effect of ablated airway blood flow on systemic and pulmonary microvascular permeability after smoke inhalation in sheep. Burns 2007;33:885-91.
2. Cox RA, Burke AS, Soejima K, et al. Airway obstruction in sheep with burn and smoke inhalation injuries. Am J Respir Cell Mol Biol 2003;29:295-302.
3. Enkhbaatar P, Murakami K, Cox R, et al. Aerosolized tissue plasminogen activator improves pulmonary function in sheep with burn and smoke inhalation. Shock 2004;22:70-5.
4. Idell S, Mazar AP, Bitterman P, Mohla S, Harabin AL. Fibrin turnover in lung inflammation and neoplasia. Am J Respir Crit Care Med 2001;163:578-84.
5. Gunter A, Mosavi P, Heinemann S, et al. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Res Crit Care Med 2000;161:454-62.
6. García-Avello A, Lorente JA, Cesar-Perez J, et al. Hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma. Thromb Res 1998; 89:59-64.
7. Seeger W, Stohr G, Wolf HRD, Neuhof H. Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 1985;58:326-38.
8. Ciana PS, Colvin RB, Dvorak AM, McDonagh J, Dvorak HF. Microphage migration in fibrin gel matrices. Lab Invest 1986;54:62-70.
9. Colvin RB, Gardner PI, Roblin RO, Verderber EL, Lanigan JM, Mosesson MW. Cell surface fibrinogen-fibrin receptors on cultured human fibroblasts: association with fibronectin (cold insoluble globulin, LETS protein) and loss in SV40 transformed cells. Lab Invest 1979;41:464-73.
10. Brown M, Desai M, Traber LD, Herndon DN, Traber DL. Dimethylsulfoxide with heparin in the treatment of smoke inhalation injury. J Burn Care Rehabil 1988;9:22-5.
11. Murakami K, McGuire R, Cox RA, et al. Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep. Shock 2002;18:236-41.
12. Murakami K, Enkhbaatar P, Shimoda K, et al. High-dose heparin fails to improve acute lung injury following smoke inhalation in sheep. Clin Sci (Lond) 2003;104:349-56.
13. Murakami K, Enkhbaatar P, Morita N, et al. The elevation of airway antithrombin level in smoke inhalation with pneumonia in sheep. Crit Care Med 2003;31:A28.
14. Enkhbaatar P, Cox R, Traber LD, et al. Aerosolized anticoagulants ameliorate acute lung injury in sheep after exposure to burn and smoke inhalation. Crit Care Med 2007;12: 2805-10.
15. Enkhbaatar P, Esichie A, Wang J, et al. Combined anticoagulants ameliorate acute lung injury in sheep after burn and smoke inhalation. Clin Sci (Lond) 2008;114:321-9.
16. Kowal-Vern A, Walenga JM, McGill V, Gameli RL. The impact of antithrombin (H) concentrate infusions on pulmonary function in the acute phase of thermal injury. Burns 2001;27:52-60.
17. Kowal-Vern A, McGill V, Walenga JM, Gameli RL. Antithrombin III concentrate in the acute phase of thermal injury. Burns 2000;26:97-101.
18. Olson ST, Bjork I. Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects. J Biol Chem 1991 ;266: 6353-64.
19. Olson ST, Bjork I, Sheffer R, Craig PA, Shore JD, Choay J. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J Biol Chem 1992;267: 12528-38.
20. Senden NH, Jeunhomme TM, Heemskerk JW, et al. Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. J Immunol 1998;161:4318-24.
21. Desai MH, Mlcak R, Richardson J, Nichols R, Herndon DN. Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/N-acetylcysteine therapy. J Burn Care Rehabil 1998;19:210-2.
22. Tasaki O, Mozingo DW, Dubick MA, Goodwin CW, Yantis LD, Pruitt BA Jr. Effects of heparin and lisofylline on pulmonary function after smoke inhalation injury in an ovine model. Crit Care Med 2002;30:637-43.
23. Adoun M, Frat JP, Dore P, Rouffineau J, Godet C, Robert R. Comparison of nebulized epinephrine and terbutaline in patients with acute severe asthma: a controlled trial. J Crit Care 2004;19:99-102.